Sanofi pulls Lyxumia's US filing - PMLiVE
Sanofi pulls out of mRNA COVID vaccine development - TeleTrader.com
Stocks To Watch: Sanofi Sees Relative Strength Rating Jump To 83 | Investor's Business Daily
Sanofi stock falls as breast cancer drug amcenestrant development stopped as trial fails | Seeking Alpha
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up
Sanofi improves workforce insights with real-time data across the globe.
Sanofi-Aventis-Pulls-Drug-Application
ConAgra, Roche, Sanofi-Aventis and RadioShack Pull Advertisements from Fox News Channel's Glenn Beck | Color Of Change
Sanofi quietly pulls the plug on its Zika vaccine project - STAT
Sanofi abandoning Auvi-Q after dosage problems led to total recall
Dupixent sales of €10B? We're on track, Sanofi CEO Hudson says | Fierce Pharma
Sanofi pulls out of late-phase Daiichi vaccine collaboration | Fierce Biotech
Sanofi pulls out of Revolution Medicines deal on SHP2 inhibitor RMC-46
Sanofi CEO Hudson singles out his digital ambitions in big executive shakeup | Fierce Pharma
Sanofi pulls Zantac from US, Canada; FDA slams Chinese API manufacturer; DMF guidance update | Radio Compass Blog
Sanofi pulls out patent plea for TB drug in EU, but not in India - Times of India
Over-the-counter heartburn drug Zantac pulled in US, Canada | WPBN
Regulators OK restart LentiVector delivered eye drug trials
Sanofi, Regeneron's Praluent pulls off PCSK9 coup with 29% cut to death risks in most vulnerable patients | Fierce Pharma
Sanofi to pull the plug on mRNA Covid-19 vaccine after rivals' success
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract | Fierce Pharma
